← Leaderboards
Pradeep Natarajan
Massachusetts General Hospital
$19,143,655
Attributed
$33,273,873
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,273,873 · 10
By mechanism
R01$21,048,631 · 7
UM1$6,922,231 · 1
U01$4,959,712 · 1
K08$343,299 · 1
Top collaborators
- Gina Marie Peloso12 shared
- Neil C Chi5 shared
- Matthew S Freiberg5 shared
- Priscilla Y. Hsue5 shared
- Kristin Ardlie4 shared
- Christie M Ballantyne4 shared
- Niall John Lennon4 shared
- Karen Conneely3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Gina Marie Peloso$4,459,562
- Joshua Lawrence Roffman$9,256,894
- Patrick Ansel Turley$3,739,825
- Stephen V Faraone$22,345,408
- Robert A Levine$14,709,794
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesGeneticRisk FactorsPhenotypeCohortGenotypeCardiovascular SystemPrevalenceVariantProgramsMutationBiobankCardiovascular DiseasesGenome Wide Association StudyAtherosclerosisInsightPreventData SetGenome SequencingExome SequencingTrans-Omics For Precision MedicineCellsGenetic AnalysisCoronary Heart Disease
Grant awards (40)
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$3,080,661
UM1 · FY2025 · DA
Enabling improved applicability and transferability of polygenic scores across populations$983,466
U01 · FY2025 · HG · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$732,435
R01 · FY2025 · HL
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$645,578
R01 · FY2025 · HL
Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias$640,750
R01 · FY2025 · HL · contact PI
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$175,455
R01 · FY2025 · HL
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$2,831,245
UM1 · FY2024 · DA
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians$988,055
U01 · FY2024 · HG · contact PI
Using genetic variation to study biology of blood lipids & coronary heart disease$730,677
R01 · FY2024 · HL
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$721,691
R01 · FY2024 · HL
Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias$697,700
R01 · FY2024 · HL · contact PI
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$624,385
R01 · FY2024 · HL
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$159,485
R01 · FY2024 · HL
Exploration and benchmarking of duplex sequencing$88,916
UM1 · FY2024 · DA
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians$992,118
U01 · FY2023 · HG · contact PI
Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT)$921,409
UM1 · FY2023 · DA
Using genetic variation to study biology of blood lipids & coronary heart disease$746,085
R01 · FY2023 · HL
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)$741,038
R01 · FY2023 · HL
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$662,051
R01 · FY2023 · HL
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial$615,128
R01 · FY2023 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$530,006
R01 · FY2023 · HL · contact PI
Using genetic variation to study biology of blood lipids & coronary heart disease$278,223
R01 · FY2023 · HL
Clonal hematopoiesis in humans: determinants of development and progression$1,441,860
R01 · FY2022 · HL
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians$996,075
U01 · FY2022 · HG · contact PI
Using genetic variation to study biology of blood lipids & coronary heart disease$748,631
R01 · FY2022 · HL
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial$615,128
R01 · FY2022 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$532,819
R01 · FY2022 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,425,387
R01 · FY2021 · HL
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians$999,998
U01 · FY2021 · HG · contact PI
Using genetic variation to study biology of blood lipids & coronary heart disease$821,176
R01 · FY2021 · HL
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial$608,663
R01 · FY2021 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$543,747
R01 · FY2021 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,470,291
R01 · FY2020 · HL
Stress-rest calf muscle perfusion: a functional diagnostic test for peripheral arterial disease (PAD)$817,992
R01 · FY2020 · HL · contact PI
Clonal hematopoiesis of indeterminate potential and HIV in the REPRIEVE trial$625,978
R01 · FY2020 · HL · contact PI
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$544,954
R01 · FY2020 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,532,120
R01 · FY2019 · HL
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids$619,198
R01 · FY2019 · HL · contact PI
Understanding modifiers of mendelian mutation penetrance using familial hypercholesterolemia as a model$170,003
K08 · FY2019 · HL · contact PI
Understanding modifiers of mendelian mutation penetrance using familial hypercholesterolemia as a model$173,296
K08 · FY2018 · HL · contact PI